APA (7th ed.) Citation

Jamison, T., Jabbour, E., Karrar, O., Jain, N., Haddad, F. G., Kebriaei, P., . . . Short, N. J. (2026). Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: Implications for the optimal frequency of MRD monitoring. Leukemia & Lymphoma, 1. https://doi.org/10.1080/10428194.2026.2679593

Chicago Style (17th ed.) Citation

Jamison, Trevor, et al. "Latency Between Detectable Low-level MRD by Next-generation Sequencing and Overt Relapse in ALL: Implications for the Optimal Frequency of MRD Monitoring." Leukemia & Lymphoma 2026: 1. https://doi.org/10.1080/10428194.2026.2679593.

MLA (9th ed.) Citation

Jamison, Trevor, et al. "Latency Between Detectable Low-level MRD by Next-generation Sequencing and Overt Relapse in ALL: Implications for the Optimal Frequency of MRD Monitoring." Leukemia & Lymphoma, 2026, p. 1, https://doi.org/10.1080/10428194.2026.2679593.